(Q44794032)

English

Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Geneviève Chêne

7

object named as

G Chene

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

J-M Molina

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

G Peytavin

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

S Perusat

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

C Lascoux-Combes

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

D Sereni

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

W Rozenbaum

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

99-104

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Daily dosing of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individuals.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00194.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2004.00194.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44794032&oldid=2144463387"